Podravka stock carries a three segment growth story

Published on 10/08/2026 at 01:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Podravka stock posted EUR 41.1 million in normalized H1 2026 profit on July 23. Revenue rose 1.7 percent as the group held profitability steady.

Podravka, HRPODRRA0004, Illustration mit AI erstellt.

Podravka stock carries a three-segment growth story built around food, agriculture and pharmaceuticals. The Croatian group reported normalized net profit of EUR 41.1 million for the first half of 2026, while revenue increased 1.7 percent.

Profitability holds in H1 2026

Index reported on July 23, 2026, that Podravka Group generated normalized net profit of EUR 41.1 million in H1 2026. The figure kept profitability at a level comparable with the prior-year period despite greater macroeconomic uncertainty.

ESM Magazine reported that H1 2026 revenue rose 1.7 percent. This comparison puts the profit figure in context: Podravka preserved normalized earnings while expanding sales.

Three businesses shape the group

Podravka says its operations span Food, Agriculture and Pharmaceuticals, with more than 8,400 employees and a portfolio of over 1,900 products. The company operates in more than 60 markets, and two-thirds of revenue comes from international markets, according to its corporate governance page.

The business mix gives the H1 result a broader operating base than a single-brand food company. Vegeta, Lino, Dolcela, Fant, Neofen, Belje and other brands sit alongside agriculture and pharmaceutical activities, linking consumer demand with a wider regional platform.

Podravka stock remains a Zagreb listing

Podravka trades under ticker PODR on the Zagreb Stock Exchange in EUR. The listing is tracked as PODR:ZSE, while the group reports its operating performance through the three segments and the wider international network.